diclofenac and 2-anilinophenylacetic acid

diclofenac has been researched along with 2-anilinophenylacetic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blobaum, AL; Marnett, LJ1
Allegretti, M; Aramini, A; Aschi, M; Bertini, R; Bizzarri, C; Cesta, MC; Crucianelli, M; Di Bitondo, R; Di Giacinto, C; Gloaguen, I; Moriconi, A; Sablone, MR1
Gu, MB; Joeng, CB; Lee, SJ; Niazi, JH1
Banerjee, S; Marnett, LJ; Valk, PL; Windsor, MA; Xu, S1
Boon, N; Hennebel, T; Meerburg, F; Vanhaecke, L; Verstraete, W1

Other Studies

5 other study(ies) available for diclofenac and 2-anilinophenylacetic acid

ArticleYear
Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.
    The Journal of biological chemistry, 2007, Jun-01, Volume: 282, Issue:22

    Topics: Amino Acid Substitution; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Kinetics; Male; Membrane Proteins; Mice; Models, Molecular; Mutation, Missense; Protein Binding; Protein Structure, Tertiary; Sheep; Time Factors

2007
Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors.
    Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

    Topics: Allosteric Regulation; Allosteric Site; Chemistry, Organic; Chemistry, Pharmaceutical; Chemotaxis; Humans; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Molecular Conformation; Mutagenesis; Mutation; Receptors, Interleukin-8A; Structure-Activity Relationship

2009
ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid.
    Bioorganic & medicinal chemistry, 2009, Aug-01, Volume: 17, Issue:15

    Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Aptamers, Nucleotide; Base Sequence; Binding Sites; Diclofenac; DNA, Single-Stranded; Nucleic Acid Conformation; Phenylacetates; SELEX Aptamer Technique

2009
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
    Bioorganic & medicinal chemistry letters, 2013, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Endocannabinoids; Mice; Molecular Docking Simulation

2013
Diclofenac and 2-anilinophenylacetate degradation by combined activity of biogenic manganese oxides and silver.
    Microbial biotechnology, 2012, Volume: 5, Issue:3

    Topics: Aniline Compounds; Biodegradation, Environmental; Diclofenac; Manganese Compounds; Oxidation-Reduction; Oxides; Phenylacetates; Pseudomonas putida; Silver; Water Pollutants, Chemical; Water Purification

2012